# Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer

> **NCT01824901** · PHASE1,PHASE2 · COMPLETED · sponsor: **ECOG-ACRIN Cancer Research Group** · enrollment: 2 (actual)

## Conditions studied

- Recurrent Non-small Cell Lung Cancer
- Squamous Cell Lung Cancer

## Interventions

- **DRUG:** docetaxel
- **DRUG:** AZD4547

## Key facts

- **NCT ID:** NCT01824901
- **Lead sponsor:** ECOG-ACRIN Cancer Research Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-15
- **Primary completion:** 2014-07-09
- **Final completion:** 2015-04
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2023-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01824901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01824901, "Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01824901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*